Engineers Gate Manager LP Kala Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $18,448 - $55,648	-30,244 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $35,083 - $82,868	30,244 New	30,244 $37,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $65,273 - $105,135	-12,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.24 - $9.58 $80,496 - $123,582	12,900 New	12,900 $87,000
Q4 2018 Feb 14, 2019	SELL	$4.29 - $9.94 $108,185 - $250,666	-25,218 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$9.54 - $13.87 $240,579 - $349,773	25,218 New	25,218 $249,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $11.3M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.